151 related articles for article (PubMed ID: 20955461)
1. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
[TBL] [Abstract][Full Text] [Related]
2. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
[TBL] [Abstract][Full Text] [Related]
3. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization.
Li G; Zhang H; Zhou W; Ye Q; Li F; Wang H; Hou Q; Xu Y; Ma X; Tan Y; Wang L; Li Y; Li H; Meng F; Liang Q; Liu A; Qin C; Wei W; Liu J; Ruan C; Tao W; Zhang S; Zheng H; Zhu F
Vaccine; 2010 Jun; 28(25):4215-23. PubMed ID: 20399240
[TBL] [Abstract][Full Text] [Related]
6. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.
Bender JM; Cox CM; Mottice S; She RC; Korgenski K; Daly JA; Pavia AT
Clin Infect Dis; 2010 Apr; 50(7):e41-6. PubMed ID: 20178414
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S
J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
Adam HJ; Richardson SE; Jamieson FB; Rawte P; Low DE; Fisman DN
Vaccine; 2010 May; 28(24):4073-8. PubMed ID: 20398617
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
12. Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance.
Giufrè M; Cardines R; Caporali MG; Accogli M; D'Ancona F; Cerquetti M
Vaccine; 2011 May; 29(22):3857-62. PubMed ID: 21459175
[TBL] [Abstract][Full Text] [Related]
13. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
[TBL] [Abstract][Full Text] [Related]
14. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
[TBL] [Abstract][Full Text] [Related]
15. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines.
Käyhty H
Biologicals; 1994 Dec; 22(4):397-402. PubMed ID: 7779368
[TBL] [Abstract][Full Text] [Related]
16. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
[TBL] [Abstract][Full Text] [Related]
18. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
Kurikka S; Käyhty H; Peltola H; Saarinen L; Eskola J; Mäkelä PH
Pediatrics; 1995 Jun; 95(6):815-22. PubMed ID: 7761204
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.
Tejedor JC; Moro M; Merino JM; Gómez-Campderá JA; García-del-Rio M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Ruiz-Contreras J; Martin-Ancel A; Roca J; Boceta R; García-Corbeira P; Maechler G; Boutriau D;
Pediatr Infect Dis J; 2008 Jul; 27(7):579-88. PubMed ID: 18536619
[TBL] [Abstract][Full Text] [Related]
20. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.
Ramsay ME; McVernon J; Andrews NJ; Heath PT; Slack MP
J Infect Dis; 2003 Aug; 188(4):481-5. PubMed ID: 12898433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
